MW150 Dementia Drug May Reduce Brain Inflammation During Withdrawal
Researchers at the University of Kentucky report that an experimental dementia drug called MW150 may calm the brain inflammation linked to alcohol withdrawal, showing promise in lab and animal tests. The compound targets a specific inflammation pathway, and early results suggest it can reduce inflammatory markers tied to relapse risk, but real-world benefit is still...